Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase

被引:38
作者
Balzarini, J
Degrève, B
Esteban-Gamboa, A
Esnouf, R
De Clercq, E
Engelborghs, Y
Camarasa, MJ
Pérez-Pérez, MJ
机构
[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain
[2] Wellcome Trust Ctr Human Genet, Struct Biol Div, Oxford OX3 7BN, England
[3] Katholieke Univ Leuven, Lab Chem & Biol Dynam, B-3000 Louvain, Belgium
来源
FEBS LETTERS | 2000年 / 483卷 / 2-3期
关键词
thymidine phosphorylase; multisubstrate inhibitors; nucleotide analogues;
D O I
10.1016/S0014-5793(00)02101-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A kinetic analysis was performed for the novel 1-(8-phosphonooctyl)-6-amino-5-bromouracil and 1-(8-phosphonooetyl)-7-deazaxanthine inhibitors of Escherichia coli thymidine (dThd) phosphorylase (TPase), The structure of the compounds was rationally designed based on the available crystal structure coordinates of bacterial TPase, These inhibitors reversibly inhibited TPase, Kinetic analysis revealed that the compounds inhibited TPase in a purely competitive or mixed fashion not only when dThd, but also when inorganic phosphate (Pi), was used as the variable substrate. In contrast, the free bases 6-amino-5-bromouracil and 7-deazaxanthine behaved as non-competitive inhibitors of the enzyme in the presence of variable Pi concentrations while being competitive or mixed with respect to thymine as the natural substrate. Our kinetic data thus revealed that the novel 1-(8-phosphonooctyl)pyrimidine/purine derivatives are able to function as multisubstrate inhibitors of TPase, interfering at two different sites (dThd(Thy)- and phosphate-binding site) of the enzyme. To our knowledge, the described compounds represent the first type of such multisubstrate analogue inhibitors of TPase; they should be considered as lead compounds for the development of mechanistically novel type of TPase inhibitors. (C) 2000 Federation of European Biochemical Societies; Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 19 条
  • [1] 7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase
    Balzarini, J
    Gamboa, AE
    Esnouf, R
    Liekens, S
    Neyts, J
    De Clercq, E
    Camarasa, MJ
    Pérez-Pérez, MJ
    [J]. FEBS LETTERS, 1998, 438 (1-2) : 91 - 95
  • [2] Cole C, 1999, ANTI-CANCER DRUG DES, V14, P411
  • [3] Further additions to MolScript version 1.4, including reading and contouring of electron-density maps
    Esnouf, RM
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 : 938 - 940
  • [4] Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase
    Esteban-Gamboa, A
    Balzarini, J
    Esnouf, R
    De Clercq, E
    Camarasa, MJ
    Pérez-Pérez, MJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (05) : 971 - 983
  • [5] THYMIDINE PHOSPHORYLASE-ACTIVITY OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR IS RESPONSIBLE FOR ENDOTHELIAL-CELL MITOGENICITY
    FINNIS, C
    DODSWORTH, N
    POLLITT, CE
    CARR, G
    SLEEP, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 212 (01): : 201 - 210
  • [6] ANGIOGENIC FACTOR
    FURUKAWA, T
    YOSHIMURA, A
    SUMIZAWA, T
    HARAGUCHI, M
    AKIYAMA, S
    FUKUI, K
    ISHIZAWA, M
    YAMADA, Y
    [J]. NATURE, 1992, 356 (6371) : 668 - 668
  • [7] Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy
    Griffiths, L
    Stratford, IJ
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (06) : 689 - 693
  • [8] HITCHINGS GH, 1959, Patent No. 812366
  • [9] ILSTZSCH MH, 1985, BIOCHEMISTRY-US, V24, P6799
  • [10] INHIBITION OF THYMIDINE PHOSPHORYLASE BY 6-AMINOTHYMINE AND DERIVATIVES OF 6-AMINOURACIL
    LANGEN, P
    ETZOLD, G
    BARWOLFF, D
    PREUSSEL, B
    [J]. BIOCHEMICAL PHARMACOLOGY, 1967, 16 (09) : 1833 - &